EDGAR Filing Documents for 0001144204-11-033898

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001144204-11-033898

Filing Date

2011-06-03

Accepted

2011-06-03 16:02:28

Documents

Period of Report

2011-04-30

Document Format Files

Seq	Description	Document	Type	Size
1		v224868_10q.htm	10-Q	1056184
2		v224868_ex10-1.htm	EX-10.1	10556
3		v224868_ex10-4.htm	EX-10.4	37647
4		v224868_ex10-5.htm	EX-10.5	40370
5		v224868_ex10-6.htm	EX-10.6	14857
6		v224868_ex10-7.htm	EX-10.7	14804
7		v224868_ex10-8.htm	EX-10.8	14814
8		v224868_ex10-9.htm	EX-10.9	14824
9		v224868_ex10-10.htm	EX-10.10	14868
10		v224868_ex10-11.htm	EX-10.11	14672
11		v224868_ex31-1.htm	EX-31.1	15025
12		v224868_ex31-2.htm	EX-31.2	14775
13		v224868_ex32.htm	EX-32	7498
	Complete submission text file	0001144204-11-033898.txt		1271926

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)